Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Ovarian Neoplasms 2Uveal Melanoma 1Smoking Cessation 1Pancreatic Neoplasms 1Overweight 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammation 1Healthy Diet 1Fatigue 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

pembrolizumab 24Carboplatin 21Paclitaxel 20olaparib 19Magnetic Resonance Spectroscopy 14Bevacizumab 14Cyclophosphamide 12Specimen Handling 11Nivolumab 11Gemcitabine 11Taxes 10niraparib 8Cisplatin 8Biopsy 8liposomal doxorubicin 7fludarabine 7Surveys and Questionnaires 6Immunoglobulin G 6Doxorubicin 6Disulfides 6durvalumab 5palbociclib 4oregovomab 4X-Rays 4Ipilimumab 4mirvetuximab soravtansine 3ipatasertib 3defactinib 3cediranib 3atezolizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Ovarian Neoplasms × Diet Therapy × Clear all
NCT02194387 2026-03-09

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

M.D. Anderson Cancer Center

Phase NA Active not recruiting
337 enrolled
BreastGastrointestinalGynecologicLymphoidOther hematologic neoplasm

Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Fatigue, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Overweight

NCT04310826 2026-02-17

Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
26 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡